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Purpose: To identify novel genes involved in osteoarthritis (OA)
we performed a Genome-Wide Association Study (GWAS) in
Caucasians.
Methods: In total, 500,510 Single Nucleotide Polymorphisms
(SNPs) were tested for association with osteoarthritis in 1341
OA cases and 3496 Dutch Caucasian Controls. SNPs nominally
associated with at least two OA-phenotypes were analyses in 11
replication studies. In the meta-analysis, 14,938 OA cases and
approximately 39,000 controls were analyzed using the program
Comprehensive Meta-Analysis. A p-value <1×10-7 was consid-
ered genome-wide signiﬁcant (0.05/500,510).
Results: The C-allele of rs3815148 on chromosome 7q22 (MAF
23%, 172 kb upstream of the GPR22 gene) was consistently
associated with a 1.14-fold increased risk (95%CI: 1.09-1.19) for
knee/hand OA (p=8×10-8), and also with an 18% increased risk for
OA progression (p=0.03). This SNP is in almost complete linkage
disequilibrium with rs3757713 (located 68 kb upstream of GPR22)
which is associated with GPR22 expression levels in lymphoblast
cell lines (p=4×10-12). In addition, immunohistochemistry showed
absence of GPR22-protein in normal murine joint tissues, but
detectable levels in arthritic disease in both the articular cartilage
and osteophytes.
Conclusions: Our ﬁndings reveal a novel common variant to
inﬂuence susceptibility for osteoarthritis.
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CYTOKINE-INDUCED CHANGES IN GENE EXPRESSION IN
SHORT-TERM CULTURES DO NOT FULLY MIMIC
ABERRANT EXPRESSION IN OSTEOARTHRITIS:
ADVANTAGES OF LONG-TERM CULTURES
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1Univ. of Southampton, Southampton, United Kingdom; 2Weill
Cornell Med. Coll., New York, NY
Purpose: Cartilage destruction in osteoarthritis (OA) is due, in
part, to cytokine-induced expression of proteases. In vivo, this
aberrant expression is maintained even in the absence of cy-
tokines and is transmitted to daughter cells, suggesting that epi-
genetic changes result in activating previously silenced genes.
Current in vitro models used for studying transcriptional regulation
consist of treating chondrocytes (primary or the cell line C28/I2)
with cytokines (IL-1β, TNF-α) and investigating gene expression
after a few hours. Many studies have shown that the cytokines
up-regulate catabolic and down-regulate anabolic genes in vitro,
but to what extent does this mimic the situation in OA? We
asked i) whether aberrant expression in vitro was maintained af-
ter cytokine withdrawal; ii) whether it was possible to reproduce
epigenetic changes in vitro and iii) to what extent the cytokine-
induced changes in vitro correlated with in vivo expression by OA
chondrocytes.
Methods: C28/I2 cells were treated with IL-1β and harvested af-
ter 1, 4, 8, 24 and 72 h. Non-OA chondrocytes, obtained after
hemi-arthroplasty, were passaged (P1), then treated once with
IL-1β and harvested after 24 and 72 h. P1 chondrocytes were
also cytokine-treated twice a week for 2-3 weeks, then pas-
saged again and cultured without cytokines for another 2 - 3
weeks. Expression levels of catabolic (IL-1β, TNF-α, MMP-3, -13)
and anabolic (COL2A1, DNMT1) genes were quantiﬁed by qRT-
PCR. DNA methylation was quantiﬁed at a key CpG site of IL-1β
promoter (Epigenetics, 2007; 2: 86-95). mRNA expression was
compared between superﬁcial-zone OA chondrocytes and aged
non-OA chondrocytes.
Results: In C28/I2 cells, induction of catabolic genes by IL-1β
rapidly peaked at 1 - 8 h, depending on the gene investigated, then
declined again. In primary chondrocytes, expression of catabolic
genes increased considerably 24 h after IL-1β treatment, but
decreased after cytokine withdrawal. COL2A1 expression was vir-
tually abolished by IL-1β and not regained after 72 h. The % DNA
methylation did not change during 72 h. Repeated treatment with
IL-1β in long-term culture increased expression of IL-1β and the
MMPs more markedly than single treatment and induced loss of
DNA methylation. Expression and DNA de-methylation was main-
tained after cytokine withdrawal and passaging. While induction of
catabolic genes was also found in superﬁcial-zone OA chondro-
cytes, the repression of anabolic genes was not. Compared with
non-OA ‘old’ chondrocytes, which expressed very low levels of
COL2A1, BMP-7 or IL1R antagonist, these genes were actually
activated in OA chondrocytes.
Conclusions: The widely used short-term cytokine-treated chon-
drocyte cultures do not fully model the in vivo situation for two
reasons: i) Repression of anabolic genes by IL-1β, which is fre-
quently observed in vitro, does not occur in OA, where activation
is observed. ii) Induction of catabolic genes is not maintained in
short-term cultures after cytokine withdrawal and does not corre-
late with DNA de-methylation, whereas in OA it does. However,
long-term treatment can mimic the loss of DNA methylation and
maintain aberrant gene expression of catabolic genes even af-
ter cytokine withdrawal. This model will facilitate studies on the
mechanisms of DNA de-methylation, which might ultimately lead
to novel therapeutic approaches for the treatment of OA.
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POLYMORPHISM IN THE RUNX1 GENE ARE ASSOCIATED
WITH OSTEOARTHRITIS OF THE HIP BUT NOT OF THE
KNEE IN THE UK
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Purpose: The Runx (runt-related) family of transcription factors
are important regulators of cell fate decisions in early embryonic
development, and in differentiation of tissues. In murine embryonic
development RUNX1 is expressed in pre-chondrocytic conden-
sations, in the perichondrium and periosteum, and in immature
proliferating chondrocytes. Functional data from analysis of limb
bud cell condensations in vitro suggests that RUNX1 mediates the
onset of mesenchymal cell commitment towards chondrogenesis.
